FindTrial
Sign In

1-month DAPT

DRUG3 trials

Sponsors

Kyoto University, Graduate School of Medicine, iVascular S.L.U.

Conditions

Acute Coronary SyndromeCoronary Artery Disease

Phase 3

Ischemic and Bleeding Outcomes After Angiolite Stent Implantation and an Abbreviated Dual Antiplatelet Therapy
RecruitingNCT05952206
iVascular S.L.U.Coronary Artery Disease
Start: 2023-10-13End: 2030-08-31Target: 2312Updated: 2025-05-16

Phase 4

ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study
CompletedNCT02619760
Kyoto University, Graduate School of MedicineCoronary Artery Disease
Start: 2015-12-31End: 2023-12-31Updated: 2024-06-14
ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 Study
Active, not recruitingNCT04609111
Kyoto University, Graduate School of MedicineAcute Coronary Syndrome
Start: 2021-01-29End: 2025-12-31Updated: 2024-06-14

Related Papers

Clopidogrel Versus Aspirin Monotherapy Beyond 1 Year After PCI: The Final 5-Year Results of the STOPDAPT-2 ACS and STOPDAPT-2 Total Cohort.
2026-03-18
Effect of Proton Pump Inhibitors in Patients Undergoing Percutaneous Coronary Intervention With Aspirin-Free Strategy.
2025-11-13
Aspirin Versus Clopidogrel Beyond 1 Month After PCI in Patients With Oral Anticoagulation
Circulation Cardiovascular Interventions2025-09-242 citations
Aspirin vs Clopidogrel 1 Month After Acute Coronary Syndrome With High-Bleeding Risk or ST-Segment Elevation.
2025-06-041 citations
Aspirin-Free Strategy for PCI in Patients With High Bleeding Risk With or Without Acute Coronary Syndrome: A Subgroup Analysis From the STOPDAPT-3 Trial
Circulation Cardiovascular Interventions2025-05-143 citations
Aspirin vs. clopidogrel monotherapy beyond 1 month after complex percutaneous coronary intervention: a pre-specified subgroup analysis of the STOPDAPT-3 trial
European Heart Journal - Cardiovascular Pharmacotherapy2025-01-25
Aspirin vs. clopidogrel monotherapy after percutaneous coronary intervention: 1-year follow-up of the STOPDAPT-3 trial
European Heart Journal2024-08-3127 citations
Post-procedural Anticoagulation With Unfractionated Heparin in Acute Coronary Syndrome: Insight from the STOPDAPT-3 Trial.
2024-07-062 citations
An Aspirin-Free Strategy for Immediate Treatment Following Complex Percutaneous Coronary Intervention.
2024-05-015 citations
An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial
Circulation2023-11-23120 citations
Clopidogrel Monotherapy After 1-Month DAPT in Patients With High Bleeding Risk or Complex PCI
JACC Asia2023-01-1015 citations
Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Patients With Diabetes Undergoing Percutaneous Coronary Intervention.
2022-12-1411 citations
Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Percutaneous Coronary Intervention: From the STOPDAPT-2 Total Cohort
Circulation Cardiovascular Interventions2022-08-0128 citations
Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome
JAMA Cardiology2022-03-02274 citations
Very Short Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients Who Underwent Complex Percutaneous Coronary Intervention: Insight From the STOPDAPT-2 Trial
Circulation Cardiovascular Interventions2021-05-0130 citations
Influence of CYP2C19 genotypes for the effect of 1-month dual antiplatelet therapy followed by clopidogrel monotherapy relative to 12-month dual antiplatelet therapy on clinical outcomes after percutaneous coronary intervention: a genetic substudy from the STOPDAPT-2.
2020-11-128 citations
Details on the effect of very short dual antiplatelet therapy after drug-eluting stent implantation in patients with high bleeding risk: insight from the STOPDAPT-2 trial.
2020-02-2141 citations
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
JAMA2019-06-25800 citations